ADXN

Addex Therapeutics Ltd Sponsored ADR · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website addextherapeutics.com
Employees(FY) 24
ISIN US00654J2069

Performance

+17.65%

1W

-49.64%

1M

-16.24%

3M

+62.16%

6M

+48.76%

YTD

-38.36%

1Y

Profile

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for pain, anxiety, and addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The CharcotMarieTooth Association. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.

Advanced Technical Analysis

Technical Analysis of ADXN 2024-05-03

Overview:

In the last 5 trading days, the stock price of ADXN has shown a downward trend, with decreasing closing prices and declining volume. The trend indicators, momentum indicators, volatility indicators, and volume indicators all point towards a bearish sentiment in the short term. Let's delve deeper into each category of indicators to prov...

See more ...

Recent News & Updates

2024-05-07 13:00
Addex to Present at Bio quity Europe 2024(Globenewswire)
2024-05-05 19:28
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday(Investorplace)
2024-04-29 19:31
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday(Investorplace)
2024-04-28 19:33
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday(Investorplace)
2024-04-28 13:00
Addex Provides Update on ADX71149 Phase 2 Epilepsy Study(Globenewswire)
2024-04-18 13:00
Addex to Present at the Swiss Biotech Day 2024(Globenewswire)
2024-04-17 18:52
ADXN Stock Earnings: Addex Therapeutics Reported Results for Q4 2023(Investorplace)
2024-04-17 13:00
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update(Globenewswire)
2024-04-10 13:00
Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024(Globenewswire)
2024-04-02 13:00
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders(Globenewswire)
2024-03-13 14:00
Addex to Present at the Bio-Europe Spring 2024 Conference(Yahoo Finance)
2024-01-30 12:00
Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.(Yahoo Finance)
2024-01-08 12:00
Addex to Present at the Swiss Equities Baader Conference(Globenewswire)
2024-01-04 12:30
Addex to Present at Biotech Showcase 2024(Globenewswire)
2023-12-19 12:00
Addex Shareholders Approve All Resolutions at Extraordinary General Meeting(Globenewswire)
2023-12-13 12:00
Addex Creates Treasury Shares(Globenewswire)
2023-11-28 12:21
Addex Therapeutics Posts Narrower Loss In Q3 - Quick Facts(Rttnews)
2023-11-28 12:00
Addex Reports Q3 2023 Financial Results and Provides Corporate Update(Globenewswire)
2023-11-27 12:00
Addex Convenes Extraordinary General Meeting(Globenewswire)
2023-11-22 12:00
Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on November 29, 2023(Globenewswire)
2023-11-13 12:00
Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment of Patients(Globenewswire)
2023-11-07 12:00
Addex Regains Nasdaq Listing Compliance(Globenewswire)
2023-11-01 14:00
Addex Announces Participation in the Bio-Europe 2023 Conference(Globenewswire)
2023-10-19 13:00
Addex Completes ADS Ratio Change(Globenewswire)
2023-10-06 04:00
Addex Announces Plan to Implement ADS Ratio Change(Globenewswire)
2023-10-04 23:20
Addex Therapeutics focused on securing new partnerships to fund promising treatments(Yahoo Finance)
2023-09-19 13:00
Addex mGlu2 NAM Cognition Program Receives 4 Million Grant(Yahoo Finance)
2023-09-05 13:00
Addex Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference(Yahoo Finance)
2023-09-04 13:00
Addex ADX71149 Phase 2 Epilepsy Study Expected to Readout Data in Q2 2024(Yahoo Finance)
2023-09-03 13:00
Addexs Dipraglurant Development in Post-Stroke Recovery Supported by Data Published in Brain(Yahoo Finance)

Page 1 of 4

previousnext